(Q41501156)

1 October 2017

Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man. (English)

1 reference

1 October 2017

0 references

B H Lauterburg

1

1 reference

1 October 2017

E L Todd

series ordinal

2

1 reference

1 October 2017

C V Smith

series ordinal

3

1 reference

1 October 2017

J R Mitchell

series ordinal

4

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 July 1985

1 reference

1 October 2017

1 reference

1 October 2017

5

1 reference

1 October 2017

607-609

1 reference

1 October 2017

4

1 reference

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

1 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050414

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050414

7 January 2021

Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050414

7 January 2021

Interaction of Cimetidine with Liver Microsomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050414

7 January 2021

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050414

7 January 2021

Risk Factors for Isoniazid (INH)-Induced Liver Dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050414

7 January 2021

Identifiers

DOI

10.1002/HEP.1840050414

1 reference

1 October 2017

1 reference